Green Farm Biotech Corp

Sangamo BioSciences, founded in 1995 and located in Richmond, Calif., is focused on the research and development of novel transcription factors for the regulation of gene expression. The company s most advanced therapeutic development program involves the use of transcription factors for the treatment of cardiovascular disease. Its other therapeutics development programs are focused on cancer, neuropathic pain, ophthalmic and infectious diseases. Sangamo s proprietary technology enables the engineering of transcription factors known as zinc finger DNA binding proteins. By engineering ZFPs so that they can recognize a specific gene, Sangamo has created ZFP transcription factors that can control gene expression and cell function. The company is developing ZFP TFs as a fundamentally enabling technology for commercial applications in human therapeutics, pharmaceutical discovery, agriculture and industrial biotechnology. More than 20 leading pharmaceutical and biotechnology companies have utilized Sangamo s research. The company trades on NASDAQ under the symbol SGMO.

Innovex Biosciences, Inc. is a Richmond, CA-based company specializing in the development and supply of high-quality primary antibodies and immunohistochemistry (IHC) products. Their extensive product line includes kits, buffers, substrates, and controls validated for IHC and immunocytochemistry (ICC), catering to the needs of researchers and laboratories in the field of biosciences. Committed to innovation and customer service, Innovex Biosciences also offers technical support, workshops, and a range of educational resources to enhance user experience and product efficacy. Their dedication to providing reliable and advanced solutions positions them as a key player in the life sciences industry. Generated from the website

Quintara Biosciences, founded in 2005, is a biotechnology company that specializes in advanced life-science technologies aimed at accelerating drug discovery and development. With a focus on quality, quick, and value-driven services, Quintara offers a range of DNA sequencing and synthesis solutions tailored to enhance the competitiveness of researchers in the life sciences community. Committed to innovation and collaboration, Quintara embraces cutting-edge technologies and fosters a culture of teamwork to empower scientists in their pursuit of scientific breakthroughs. Their portfolio includes Sanger sequencing, next-generation sequencing, oligo synthesis, and custom cloning, ensuring a seamless experience for clients through responsive support and high-quality bioscience solutions. Generated from the website